Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cardiff Oncology, Inc.

3.88
+0.26007.18%
Post-market: 3.920.0383+0.99%19:48 EDT
Volume:1.15M
Turnover:4.43M
Market Cap:258.12M
PE:-4.22
High:3.93
Open:3.65
Low:3.61
Close:3.62
Loading ...

Cardiff Oncology price target raised to $17 from $13 at H.C. Wainwright

TIPRANKS
·
28 Feb

Cardiff Oncology, Inc. : H.c. Wainwright Raises Target Price to $17 From $13

THOMSON REUTERS
·
28 Feb

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Cardiff Oncology (CRDF)

TIPRANKS
·
28 Feb

Cardiff Oncology Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

William Blair Keeps Their Buy Rating on Cardiff Oncology (CRDF)

TIPRANKS
·
28 Feb

BRIEF-Cardiff Oncology Files For Mixed Shelf Of Up To $400 Million – SEC Filing

Reuters
·
28 Feb

Cardiff Oncology Inc: Qtrly Net Loss per Share $0.95

THOMSON REUTERS
·
28 Feb

Cardiff Oncology Inc: Cash and Equivalents of $91.7 Mln as of December 31, 2024, Projected Runway Into Q1 2027

THOMSON REUTERS
·
28 Feb

Cardiff Oncology Q4 GAAP EPS $(0.21) Beats $(0.24) Estimate, Sales $151.00K Beat $94.17K Estimate

Benzinga
·
28 Feb

Press Release: Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

Dow Jones
·
28 Feb

Cardiff Oncology Inc expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
26 Feb

Cardiff Oncology to Present at Upcoming Investor Conferences

GlobeNewswire
·
25 Feb

Bullish Cardiff Oncology Insiders Rewarded As Their Investment Rises To US$1.81m

Simply Wall St.
·
20 Feb

While institutions own 25% of Cardiff Oncology, Inc. (NASDAQ:CRDF), retail investors are its largest shareholders with 57% ownership

Simply Wall St.
·
23 Dec 2024

Craig-Hallum Reaffirms Their Buy Rating on Cardiff Oncology (CRDF)

TIPRANKS
·
17 Dec 2024

Cardiff Oncology price target raised to $10 from $7 at Piper Sandler

TIPRANKS
·
13 Dec 2024

CRDF Stock Soars on Robust Efficacy Data From Colorectal Cancer Study

Zacks
·
11 Dec 2024

Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More

Zacks
·
11 Dec 2024

Cardiff Oncology Reports Promising Phase 2 Trial Results

TipRanks
·
11 Dec 2024

Cardiff Oncology Shares up 44.7% After Positive Initial Data From Mid-Stage Cancer Trial

THOMSON REUTERS
·
10 Dec 2024